Related Experiment Video
Updated: Apr 21, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Invasive pulmonary infection caused by Chrysosporium articulatum: the first case report
Chusana Suankratay1, Onwalee Dhissayakamol, Noppacharn Uaprasert
1Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Abstract:
Chrysosporium species, saprobic soil fungi, comprise more than 60 species. There is some confusion regarding the taxonomy and nomenclature between Chrysosporium and Emmonsia since the causative agents of adiaspiromycosis, the development of big thick-walled spores (adiaspores) in humans or animals, were previously thought to be Chrysosporium. Chrysosporium articulatum has never been reported to cause invasive infection in humans. We report herein the first case of invasive pulmonary infection caused by Chrysosporium articulatum in a 16-year-old man with acute T-cell lymphoblastic leukaemia. He was successfully treated with voriconazole.
Insights
This study details the first invasive pulmonary infection caused by Chrysosporium articulatum in a young leukemia patient. The successful treatment with voriconazole offers hope for similar rare fungal infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Hematology
Background:
- Chrysosporium species are saprobic soil fungi with over 60 known species.
- Taxonomic confusion exists between Chrysosporium and Emmonsia, particularly regarding adiaspiromycosis.
- Chrysosporium articulatum was not previously known to cause invasive human infections.
Observation:
- A 16-year-old male with acute T-cell lymphoblastic leukemia presented with an invasive pulmonary infection.
- The infection was caused by Chrysosporium articulatum, a species previously unreported in human invasive disease.
Findings:
- This case represents the first documented instance of invasive pulmonary infection by Chrysosporium articulatum.
- The patient received successful treatment with the antifungal medication voriconazole.
Implications:
- This finding expands the known spectrum of Chrysosporium articulatum pathogenicity.
- Highlights the importance of accurate fungal identification in immunocompromised patients.
- Voriconazole demonstrates efficacy in treating rare invasive fungal infections caused by Chrysosporium species.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Fungal Phylum Microsporidia
Bacterial Phylum Chlamydiae
Fungal Phylum Ascomycota

